Immunity, inflammation and sepsis: New insights and persistent questions

Critical Care

Volumn 15, Issue 1, 2011, Pages

  Frazier, W Joshua ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE RELEASE; ENZYME ACTIVITY; EX VIVO STUDY; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; INFLAMMATION; NOTE; PHENOTYPE; PRIORITY JOURNAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ENDOTOXEMIA; FEMALE; MALE; METABOLISM;

CASPASE 1; ENDOTOXEMIA; FEMALE; HUMANS; INTERLEUKIN-1BETA; MALE; SEPSIS;

EID: 84856366083     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10028     Document Type: Note

References (11)

1. Giamarellos-Bourboulis EJ, van de Veerdonk FL, Mouktaroudi M, Raftogiannis M, Antonopoulou A, Joosten LA, Pickkers P, Savva A, Georgitsi M, van der Meer JW, Netea MG. Inhibition of caspase-1 activation in Gram-negative sepsis and experimental endotoxemia. Crit Care 2011, 15:R27. 10.1186/cc9974, 21244670.
2. Frazier WJ, Hall MW. Immunoparalysis and adverse outcomes from critical illness. Pediatr Clin North Am 2008, 55:647-668. xi, 10.1016/j.pcl.2008.02.009, 2474674, 18501759.
3. Monneret G, Lepape A, Voirin N, Bohe J, Venet F, Debard AL, Thizy H, Bienvenu J, Gueyffier F, Vanhems P. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006, 32:1175-1183. 10.1007/s00134-006-0204-8, 16741700.
4. Polk HC, Wellhausen SR, Regan M. A systematic study of host defense processes in badly injured patients. Ann Surg 1986, 204:282-297. 1251278, 3019260.
5. Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, Muller JM, Docke WD, Kox WJ. Monocyte deactivation - rationale for a new therapeutic strategy in sepsis. Intensive Care Med 1996, 22(Suppl 4):S474-S481. 10.1007/BF01743727, 8923092.
6. Nakos G, Malamou-Mitsi VD, Lachana A, Karassavoglou A, Kitsiouli E, Agnandi N, Lekka ME. Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med 2002, 30:1488-1494. 10.1097/00003246-200207000-00015, 12130967.
7. Nierhaus A, Montag B, Timmler N, Frings DP, Gutensohn K, Jung R, Schneider CG, Pothmann W, Brassel AK, Schulte Am Esch J. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med 2003, 29:646-651.
8. Rosenbloom AJ, Linden PK, Dorrance A, Penkosky N, Cohen-Melamed MH, Pinsky MR. Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients. Chest 2005, 127:2139-2150. 10.1378/chest.127.6.2139, 15947332.
9. Hall MW, Gavrilin MA, Knatz NL, Duncan MD, Fernandez SA, Wewers MD. Monocyte mRNA phenotype and adverse outcomes from pediatric multiple organ dysfunction syndrome. Pediatr Res 2007, 62:597-603. 10.1203/PDR.0b013e3181559774, 17805202.
10. Hall MW, Gavrilin MA, Knatz NL, Duncan MD, Wewers MD. Monocyte mRNA expression in pediatric multiple organ dysfunction syndrome: anti-inflammatory dominance in nonsurvivors. Crit Care Med 2005, 33:A152.
11. Pachot A, Lepape A, Vey S, Bienvenu J, Mougin B, Monneret G. Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett 2006, 106:63-71. 10.1016/j.imlet.2006.04.010, 16765452.